Founded by a group of veterans from US biopharmaceutical industries in 2004, Sundia MediTech Company Ltd. Is now a leading Shanghai-based pharmaceutical and biotech R&D out-sourcing company. Recently merged with United PharmaTech and formed alliance with HD Biosciences, Sundia offers broad and integrated services of custom organic synthesis, medicinal chemistry, process chemistry, APIs manufacturing under cGMP or non-cGMP, bioassay, and in vitro & in vivo PK studies. We have successfully established collaborations with over 45 client companies in North America, Europe, and Japan. Our professional team possesses talents from organic synthesis, medicinal chemistry, process chemistry, biology, to business management, and law. Sundia's management team members have received advanced degrees or training and have extensive working / management experiences in North America. Our research team comprises over 200 scientists, among which 16% are Ph.D.'s; 47% MS's; and 37% BS's.